Bio-Techne Releases Third Quarter Fiscal 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Janney Montgomery Scott Upgrades Techne Corp. (TECH) to Buy
May 3, 2016 12:58 PM EDTJanney Montgomery Scott upgraded Techne Corp. (NASDAQ: TECH) from Neutral to Buy with a price target of $118.00 (from $100.00).
For an analyst ratings summary and ratings history on Techne Corp. click here. For more ratings news on Techne Corp. click here.
Shares of Techne Corp. closed at $93.30 yesterday.
... MoreBio-Techne (TECH) Misses Q3 EPS by 8c
May 3, 2016 7:29 AM EDTBio-Techne (NASDAQ: TECH) reported Q3 EPS of $0.81, $0.08 worse than the analyst estimate of $0.89. Revenue for the quarter came in at $131 million versus the consensus estimate of $122.65 million.
For earnings history and earnings-related data on Bio-Techne (TECH) click here.
... More